Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Phenylpropanolamine
Vetoquinol UK Ltd
QG04BX91
Phenylpropanolamine
Syrup
POM-V - Prescription Only Medicine – Veterinarian
Dogs
Neurological Agent
Authorized
1993-01-27
Revised: September 2021 AN: 00517/2021 & 00518/2021 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT PROPALIN Syrup, 40 mg/ml Dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Phenylpropanolamine 40.28 mg (Equivalent to 50 mg phenylpropanolamine hydrochloride) EXCIPIENTS: For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Syrup. Colourless to slightly yellow-brown solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of urinary incontinence associated with urethral sphincter incompetence in the bitch. Efficacy has only been demonstrated in ovariohysterectomised bitches. 4.3 CONTRAINDICATIONS The use of Propalin is not appropriate for the treatment of behavioural causes of inappropriate urination. Do not administer to patients treated with non-selective monoamine oxidase inhibitors. Do not use in case of known hypersensitivity to active substance or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Revised: September 2021 AN: 00517/2021 & 00518/2021 Page 2 of 5 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Phenylpropanolamine, a sympathomimetic drug, may affect the cardiovascular system, especially blood pressure and heart rate, and should be used with caution in animals with cardiovascular diseases. Care should be exercised in treating animals with severe renal or hepatic insufficiency, diabetes mellitus, hyperadrenocorticism, glaucoma, hyperthyroidism or other metabolic disorders. In bitches less than 1 year old the possibility of anatomical disorders contributing to incontinence should be considered prior to treatment. Special precautions to be taken by the person administering the veterinary medicinal product to animals Phenylpropanolamine Hydrochloride is toxic when overdoses are ingested. Adverse effects may include dizziness, headache, nausea, insomnia or restlessness, and increased blood p Read the complete document